Citations (16)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Koh Miura, Tetsuhiko Shirasaka, Hiroki Yamaue & Iwao Sasaki. (2012) S-1 as a core anticancer fluoropyrimidine agent. Expert Opinion on Drug Delivery 9:3, pages 273-286.
Read now
Read now
Venkatesh Rengaswamy, Udo Kontny & Jochen Rössler. (2011) New approaches for pediatric rhabdomyosarcoma drug discovery: targeting combinatorial signaling. Expert Opinion on Drug Discovery 6:10, pages 1103-1125.
Read now
Read now
Articles from other publishers (14)
Nadia Hindi, Jaime Carrillo-García, Elena Blanco-Alcaina, Marta Renshaw, Pablo Luna, José Durán, Natalia Jiménez, Pilar Sancho, Rafael Ramos, David S. Moura & Javier Martín-Broto. (2023) Platinum-Based Regimens Are Active in Advanced Pediatric-Type Rhabdomyosarcoma in Adults and Depending on HMGB1 Expression. International Journal of Molecular Sciences 24:1, pages 856.
Crossref
Crossref
Changwu Wu, Siming Gong, Georg Osterhoff & Nikolas Schopow. (2021) A Novel Four-Gene Prognostic Signature for Prediction of Survival in Patients with Soft Tissue Sarcoma. Cancers 13:22, pages 5837.
Crossref
Crossref
Hai-yu Ji, Juan Yu, Xiao-dan Dong & An-jun Liu. (2019) Preparation of soluble dietary fibers from Gracilaria lemaneiformis and its antitumor activity in vivo. Journal of Food Measurement and Characterization 13:2, pages 1574-1582.
Crossref
Crossref
Amanda J. Saraf, Paul S. Dickman & Pooja Hingorani. (2019) Disialoganglioside GD2 Expression in Pediatric Rhabdomyosarcoma: A Case Series and Review of the Literature. Journal of Pediatric Hematology/Oncology 41:2, pages 118-120.
Crossref
Crossref
Li Mo, Yafei Chen, Wenjian Li, Shuai Guo, Xuzhao Wang, Hailong An & Yong Zhan. (2017) Anti-tumor effects of (1→3)-β-d-glucan from Saccharomyces cerevisiae in S180 tumor-bearing mice. International Journal of Biological Macromolecules 95, pages 385-392.
Crossref
Crossref
Mischa P. Keizer, Angela M. Kamp, Cathelijn Aarts, Judy Geisler, Huib N. Caron, Marianne D. van de Wetering, Diana Wouters & Taco W. Kuijpers. (2016) The High Prevalence of Functional Complement Defects Induced by Chemotherapy. Frontiers in Immunology 7.
Crossref
Crossref
Patrizia Gasparini, Michela Casanova, Raffaella Villa, Paola Collini, Rita Alaggio, Angelica Zin, Paolo Bonvini, Cristina R Antonescu, Renata Boldrini, Roberto Caserini, Massimo Moro, Giovanni Centonze, Cristina Meazza, Maura Massimino, Luca Bergamaschi, Roberto Luksch, Stefano Chiaravalli, Gianni Bisogno, Nadia Zaffaroni, MariaGrazia Daidone, Gabriella Sozzi & Andrea Ferrari. (2016) Anaplastic lymphoma kinase aberrations correlate with metastatic features in pediatric rhabdomyosarcoma. Oncotarget 7:37, pages 58903-58914.
Crossref
Crossref
Jianfeng Cao, Dong Hou, Jingbo Lu, Lei Zhu, Pengying Zhang, Nan Zhou & Kaoshan Chen. (2016) Anti-tumor activity of exopolysaccharide from Rhizopus nigricans Ehrenb on S180 tumor-bearing mice. Bioorganic & Medicinal Chemistry Letters 26:8, pages 2098-2104.
Crossref
Crossref
Sander M. Botter, Matthias J.E. Arlt, Walter Born & Bruno Fuchs. 2015. Bone Cancer. Bone Cancer
349
363
.
David J. Monsma, David M. Cherba, Patrick J. Richardson, Sean Vance, Sanjeet Rangarajan, Dawna Dylewski, Emily Eugster, Stephanie B. Scott, Nicole L. Beuschel, Paula J. Davidson, Richard Axtell, Deanna Mitchell, Eric P. Lester, Joseph J. Junewick, Craig P. Webb & Noel R. Monks. (2014) Using a rhabdomyosarcoma patient-derived xenograft to examine precision medicine approaches and model acquired resistance. Pediatric Blood & Cancer 61:9, pages 1570-1577.
Crossref
Crossref
Chunxiang Cao, Xunlei Zhang, Meng Kuang, Dongying Gu, Mingliang He, Jinfei Chen & Cuiju Tang. (2014) Survival benefit from S‐1 as compared to Fluorouracil in Asian patients with advanced gastrointestinal cancer: A meta‐analysis. Cancer Science 105:8, pages 1008-1014.
Crossref
Crossref
G. Cassinelli, C. Lanzi, M. Tortoreto, D. Cominetti, G. Petrangolini, E. Favini, N. Zaffaroni, C. Pisano, S. Penco, I. Vlodavsky & F. Zunino. (2013) Antitumor efficacy of the heparanase inhibitor SST0001 alone and in combination with antiangiogenic agents in the treatment of human pediatric sarcoma models. Biochemical Pharmacology 85:10, pages 1424-1432.
Crossref
Crossref
. (2012) Current World Literature. Current Opinion in Oncology 24:4, pages 454-460.
Crossref
Crossref
Patrick A. Thompson & Murali Chintagumpala. (2012) Targeted Therapy in Bone and Soft Tissue Sarcoma in Children and Adolescents. Current Oncology Reports 14:2, pages 197-205.
Crossref
Crossref